Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence D Mayer

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 19, 2005
Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomesMaria C Sandström, Ludger M Ickenstein, Lawrence D Mayer, et al.
International Journal of Pharmaceutics|February 17, 2010
Biophysical characterization of a liposomal formulation of cytarabine and daunorubicinAwa Dicko, Sungjong Kwak, April A Frazier, et al.
Biochimica Et Biophysica Acta|August 5, 2003
Disc formation in cholesterol-free liposomes during phase transitionLudger M Ickenstein, Maria C Arfvidsson, David Needham, et al.
Experimental Hematology|May 3, 2011
Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cellsHyun Pyo Kim, Brigitte Gerhard, Troy O Harasym, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Synergistic cytotoxicity of pyrazoloacridine with doxorubicin, etoposide, and topotecan in drug-resistant tumor cellsYanPing Hu, Awtar Krishan, WeiJia Nie, et al.
Cancer Biology & Therapy|January 17, 2004
Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer modelDawn N Waterhouse, Wieslawa H Dragowska, Karen A Gelmon, et al.
The Prostate|March 3, 2004
P-glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cellsMatthew N Fedoruk, Pepita Giménez-Bonafé, Emma S Guns, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 4, 2004
An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomesSheela A Abraham, Katarina Edwards, Göran Karlsson, et al.
Biochimica Et Biophysica Acta|September 13, 2002
Formation of transition metal-doxorubicin complexes inside liposomesSheela Ann Abraham, Katarina Edwards, Göran Karlsson, et al.
Oncology Research|October 5, 2007
Increased preclinical efficacy of irinotecan and floxuridine coencapsulated inside liposomes is associated with tumor delivery of synergistic drug ratiosTroy O Harasym, Paul G Tardi, Natashia L Harasym, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 19, 2005
Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomesMaria C Sandström, Ludger M Ickenstein, Lawrence D Mayer, et al.
International Journal of Pharmaceutics|February 17, 2010
Biophysical characterization of a liposomal formulation of cytarabine and daunorubicinAwa Dicko, Sungjong Kwak, April A Frazier, et al.
Biochimica Et Biophysica Acta|August 5, 2003
Disc formation in cholesterol-free liposomes during phase transitionLudger M Ickenstein, Maria C Arfvidsson, David Needham, et al.
Experimental Hematology|May 3, 2011
Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cellsHyun Pyo Kim, Brigitte Gerhard, Troy O Harasym, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Synergistic cytotoxicity of pyrazoloacridine with doxorubicin, etoposide, and topotecan in drug-resistant tumor cellsYanPing Hu, Awtar Krishan, WeiJia Nie, et al.
Cancer Biology & Therapy|January 17, 2004
Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer modelDawn N Waterhouse, Wieslawa H Dragowska, Karen A Gelmon, et al.
The Prostate|March 3, 2004
P-glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cellsMatthew N Fedoruk, Pepita Giménez-Bonafé, Emma S Guns, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 4, 2004
An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomesSheela A Abraham, Katarina Edwards, Göran Karlsson, et al.
Biochimica Et Biophysica Acta|September 13, 2002
Formation of transition metal-doxorubicin complexes inside liposomesSheela Ann Abraham, Katarina Edwards, Göran Karlsson, et al.
Oncology Research|October 5, 2007
Increased preclinical efficacy of irinotecan and floxuridine coencapsulated inside liposomes is associated with tumor delivery of synergistic drug ratiosTroy O Harasym, Paul G Tardi, Natashia L Harasym, et al.
Pageof 6